AIM
CASM

Acrospire Investment Management’s CAS Medical Systems, Inc. CASM Stock Holding History

Acrospire Investment Management’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,967
Closed -$35K – 2281
2016
Q2 		$35K Buy
+18,967
New +$35.6K 0.03% 1299

Other funds holding CASM

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
TCM
TD Capital Management Memphis, Tennessee $1.11B AUM 10.06% 1-Year Est. Return

Acrospire Investment Management's CASM Position: Q3 2016 in Review

Acrospire Investment Management sold out of CAS Medical Systems, Inc. (CASM) in Q3 2016, closing a stake of 18,967 shares — an estimated $35K sold.

Acrospire Investment Management first reported a position in CASM in Q2 2016 and held it in 1 quarter. The position peaked at $35K in Q2 2016. 19 funds tracked by Wall St. Rank hold CASM as of Q3 2016.

  • Acrospire Investment Management reported no remaining CAS Medical Systems, Inc. position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 18,967 CAS Medical Systems, Inc. shares in Q3 2016, an estimated $35K.
  • Acrospire Investment Management first reported a position in CAS Medical Systems, Inc. in Q2 2016 and held it in 1 quarter.
  • Acrospire Investment Management's CAS Medical Systems, Inc. position peaked at $35K in Q2 2016.
  • 19 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.